NEOTRAC Trial: NACCRT with Trastuzumab in HER2-Positive Inoperable Breast Cancer

Auhtors: P. Iyer, A. Krishnamurthy, S. Velusamy, S. Sundersingh, G. Selvarajan, S. Rajaram, P. Venkatraman, and V. Radhakrishnan

The phase II NEOTRAC trial is the first randomized study to evaluate neoadjuvant concurrent…